The University of Southampton
University of Southampton Institutional Repository

Evidence-based interventions for bipolar disorder (EBI-BD): a living Umbrella-Review, Evaluation, Analysis, and Communication Hub (U-REACH) project in bipolar disorder across phases and age groups

Evidence-based interventions for bipolar disorder (EBI-BD): a living Umbrella-Review, Evaluation, Analysis, and Communication Hub (U-REACH) project in bipolar disorder across phases and age groups
Evidence-based interventions for bipolar disorder (EBI-BD): a living Umbrella-Review, Evaluation, Analysis, and Communication Hub (U-REACH) project in bipolar disorder across phases and age groups
Objectives: to systematically evaluate the certainty of evidence for treatment strategies across age groups and mood phases in bipolar disorder (BD) and develop an open-access web platform to facilitate shared decision-making.

Design: umbrella review following Umbrella-Review, Evaluation, Analysis, and Communication Hub (U-REACH) framework.

Data sources: PubMed, PsycINFO, and Cochrane library databases up to November 19, 2024.

Eligibility criteria for selecting studies: systematic reviews with network meta-analyses (NMA) or pairwise meta-analyses (MA) of randomized controlled trials examining any age group, BD phase, treatment, control, or outcome. Primary outcomes included BD episode-specific symptoms and relapse, and acceptability. Secondary outcomes included response, remission, switch to mania, and tolerability. Certainty of evidence was assessed using the GRADE framework. Interventions effective across outcomes and phases were also identified. A Communication Hub Evidence Based Interventions-BD (EBI-BD) preference-based tool was developed to support shared decision-making using the TOPSIS multicriteria decision analysis method, incorporating user-defined outcome weights. Treatment effects were also grouped based on Neuroscience Based Nomenclature (NbN) classes.
Results: Seventy-seven studies met inclusion criteria (21 NMAs, 56 MAs), including 116 unique pharmacological (n=74), brain stimulation (n=18), nutraceutical (n=13), psychosocial (n=8), and circadian rhythm-based (n=3) treatments as monotherapy, augmentation, or combination therapy, plus five control interventions. These studies covered 133 unique outcomes (45 efficacy, 88 safety) resulting in 2,510 meta-analyses with GRADE certainty ratings of high (n=236), moderate (n=827), low (n=986), and very low (n=461). Full results are freely available in the EBI-BD platform [https://ebibd-database.org], including the preference-based tool (12 interventions, 17 safety outcomes). Interventions effective across outcomes varied by phases. For bipolar depression, they were cariprazine, divalproex/valproate, fluoxetine, ketamine (augmentation), lamotrigine, lumateperone, lurasidone, olanzapine, olanzapine+fluoxetine, quetiapine (adults), and olanzapine+fluoxetine (children/adolescents). For mania, they included aripiprazole, asenapine, carbamazepine, cariprazine, divalproex/valproate, haloperidol, lithium, olanzapine, paliperidone, quetiapine (also augmentation), risperidone (also augmentation), tamoxifen, ziprasidone (adults), and aripiprazole, asenapine, olanzapine, quetiapine, and risperidone (children/adolescents). For maintenance, interventions effective across outcomes were aripiprazole (also LAI), asenapine, divalproex/valproate, lithium, olanzapine, group psychoeducation (augmentation), quetiapine, and risperidone LAI (adults). Interventions effective across phases were aripiprazole (also LAI), asenapine, cariprazine, CBT (augmentation), divalproex/valproate, lithium, olanzapine, quetiapine (also augmentation), risperidone (also augmentation and LAI) (adults).
Treatment effects by NbN classes are also available in the manuscript.

Conclusions: the EBI-BD tool informs clinicians to make evidence-based, personalized treatment decisions for BD. This resource can inform clinical guidelines and provides a foundation for continuously improving BD care as new evidence emerges.

Trial registration: Open Science Framework: https://osf.io/pjmvn/

0959-8138
De Prisco, Michele
d463612d-12e8-4344-9c52-86ef341f4d2f
Oliva, Vincenzo
a6a1c672-62c6-4867-a43e-061d08b88551
Miola, Alessandro
1966d43f-01ef-4fc3-8040-d0ccb54f498a
Fornaro, Michele
b817f7f5-0787-4906-91ab-a71c87053e34
Dragioti, Elena
737161f7-ec35-4d20-80eb-5f382c0aa9b6
Croatto, Giovanni
2b0f321a-25df-457a-9f6b-776e4ae9e319
Carvalho, Andre F.
faaf51e6-a92a-485b-9d9b-f29590430a3d
Berk, Michael
7439ffb9-8b2d-4990-9a8e-93e247ca8d54
Nikolitch, Katerina
69ba6620-dbd1-43cc-a420-3021d2136b37
Saraf, Gayatri
018b13a3-7986-488a-a8f7-12e6b9b435df
Yatham, Lakshmi N.
092a6830-d8c1-4818-8176-497c2942d3cf
Keramatian, Kamyar
56886ccd-3df9-4840-9886-8d216c948fa7
Shorr, Risa
f1086166-5045-49cd-908f-a5897fc7fc03
Frye, Mark
6e8cc8aa-13e4-4ee5-bc66-b585a2aedeff
Singh, Balwinder
9eefa73a-f684-4e44-8b77-7a0030eb82a7
Krinitski, Damir
0a90fdfb-f76c-4c5a-a798-1cdc91fdcb32
Højlund, Mikkel
1ce44cef-af83-43a8-9ca4-2a2bc80e3a0e
Serretti, Alessandro
15e5146f-1ad2-4638-89c7-a579d19284ba
Fanelli, Giuseppe
0e59e109-e5bf-4398-8421-714b99506014
Alves Gomes, Fabiano
d69392c4-bd9b-4185-87ec-ad73d26510b1
Hansen, Anne Sofie
5cca4664-8f84-4cac-90c9-e685fa91e86f
Nielsen, René Ernst
2dc4171f-5518-40eb-979c-0cd804d03ca2
Fusar-Poli, Paolo
dfb80ff8-8a29-4a23-899d-e7311b855433
Paribello, Pasquale
4ac01aca-40a1-4708-a54a-fbc0cf90fb13
Manchia, Mirko
14dea2f1-0182-4b7c-b5c0-aa793f025a50
Bahji, Anees
a0bbd949-a93c-489b-9480-a2ed73547547
Vazquez, Gustavo
e7ea93d6-f32c-4628-9afd-7052421e040a
Siafis, Spyridon
71c8e17b-f221-4c85-aebe-2b14f510d552
Leucht, Stefan
aecc4c83-e8e6-4069-994e-145a33ee3309
Yildiz, Ayşegül
c31cf9cb-62b8-4c1f-8550-9b9de26aceb4
Delorme, Richard
7a080da7-d547-43a7-a9b7-5e250c381e38
Schaffer, Ayal
5c5e90a5-8916-49ec-9e43-966505cb52fe
Stubbs, Brendon
1b1916f6-b2f8-4257-84de-0c7072c4c67a
Rubaiyat, Ruby
0d22524e-dfd7-4447-8a76-756bdf0ba74d
Vieta, Eduard
0a605454-7d6f-4b8b-b0c9-0df1ed41da95
Correll, Christoph U.
64860443-88af-4c24-b83b-1e4a6572c8dc
Moher, David
d6874c09-5b51-4b18-a921-e1ec411a2b91
Cortese, Samuele
53d4bf2c-4e0e-4c77-9385-218350560fdb
Fiedorowicz, Jess G.
b15b0574-b8ea-4afb-99f0-917e57ea616d
Radua, Joaquim
62338ecf-18b6-4fe3-aa9a-ccd2ad389c19
Gosling, Corentin J.
4b27a1d3-18fb-4be5-b199-e44aaa66c8b2
Solmi, Marco
8dc5ef1e-4b0d-4047-a55b-6c4c7a93cf00
et al.
De Prisco, Michele
d463612d-12e8-4344-9c52-86ef341f4d2f
Oliva, Vincenzo
a6a1c672-62c6-4867-a43e-061d08b88551
Miola, Alessandro
1966d43f-01ef-4fc3-8040-d0ccb54f498a
Fornaro, Michele
b817f7f5-0787-4906-91ab-a71c87053e34
Dragioti, Elena
737161f7-ec35-4d20-80eb-5f382c0aa9b6
Croatto, Giovanni
2b0f321a-25df-457a-9f6b-776e4ae9e319
Carvalho, Andre F.
faaf51e6-a92a-485b-9d9b-f29590430a3d
Berk, Michael
7439ffb9-8b2d-4990-9a8e-93e247ca8d54
Nikolitch, Katerina
69ba6620-dbd1-43cc-a420-3021d2136b37
Saraf, Gayatri
018b13a3-7986-488a-a8f7-12e6b9b435df
Yatham, Lakshmi N.
092a6830-d8c1-4818-8176-497c2942d3cf
Keramatian, Kamyar
56886ccd-3df9-4840-9886-8d216c948fa7
Shorr, Risa
f1086166-5045-49cd-908f-a5897fc7fc03
Frye, Mark
6e8cc8aa-13e4-4ee5-bc66-b585a2aedeff
Singh, Balwinder
9eefa73a-f684-4e44-8b77-7a0030eb82a7
Krinitski, Damir
0a90fdfb-f76c-4c5a-a798-1cdc91fdcb32
Højlund, Mikkel
1ce44cef-af83-43a8-9ca4-2a2bc80e3a0e
Serretti, Alessandro
15e5146f-1ad2-4638-89c7-a579d19284ba
Fanelli, Giuseppe
0e59e109-e5bf-4398-8421-714b99506014
Alves Gomes, Fabiano
d69392c4-bd9b-4185-87ec-ad73d26510b1
Hansen, Anne Sofie
5cca4664-8f84-4cac-90c9-e685fa91e86f
Nielsen, René Ernst
2dc4171f-5518-40eb-979c-0cd804d03ca2
Fusar-Poli, Paolo
dfb80ff8-8a29-4a23-899d-e7311b855433
Paribello, Pasquale
4ac01aca-40a1-4708-a54a-fbc0cf90fb13
Manchia, Mirko
14dea2f1-0182-4b7c-b5c0-aa793f025a50
Bahji, Anees
a0bbd949-a93c-489b-9480-a2ed73547547
Vazquez, Gustavo
e7ea93d6-f32c-4628-9afd-7052421e040a
Siafis, Spyridon
71c8e17b-f221-4c85-aebe-2b14f510d552
Leucht, Stefan
aecc4c83-e8e6-4069-994e-145a33ee3309
Yildiz, Ayşegül
c31cf9cb-62b8-4c1f-8550-9b9de26aceb4
Delorme, Richard
7a080da7-d547-43a7-a9b7-5e250c381e38
Schaffer, Ayal
5c5e90a5-8916-49ec-9e43-966505cb52fe
Stubbs, Brendon
1b1916f6-b2f8-4257-84de-0c7072c4c67a
Rubaiyat, Ruby
0d22524e-dfd7-4447-8a76-756bdf0ba74d
Vieta, Eduard
0a605454-7d6f-4b8b-b0c9-0df1ed41da95
Correll, Christoph U.
64860443-88af-4c24-b83b-1e4a6572c8dc
Moher, David
d6874c09-5b51-4b18-a921-e1ec411a2b91
Cortese, Samuele
53d4bf2c-4e0e-4c77-9385-218350560fdb
Fiedorowicz, Jess G.
b15b0574-b8ea-4afb-99f0-917e57ea616d
Radua, Joaquim
62338ecf-18b6-4fe3-aa9a-ccd2ad389c19
Gosling, Corentin J.
4b27a1d3-18fb-4be5-b199-e44aaa66c8b2
Solmi, Marco
8dc5ef1e-4b0d-4047-a55b-6c4c7a93cf00

De Prisco, Michele, Oliva, Vincenzo and Miola, Alessandro , et al. (2026) Evidence-based interventions for bipolar disorder (EBI-BD): a living Umbrella-Review, Evaluation, Analysis, and Communication Hub (U-REACH) project in bipolar disorder across phases and age groups. British Medical Journal, 394, [e100216]. (doi:10.1136/bmj-2026-100216).

Record type: Article

Abstract

Objectives: to systematically evaluate the certainty of evidence for treatment strategies across age groups and mood phases in bipolar disorder (BD) and develop an open-access web platform to facilitate shared decision-making.

Design: umbrella review following Umbrella-Review, Evaluation, Analysis, and Communication Hub (U-REACH) framework.

Data sources: PubMed, PsycINFO, and Cochrane library databases up to November 19, 2024.

Eligibility criteria for selecting studies: systematic reviews with network meta-analyses (NMA) or pairwise meta-analyses (MA) of randomized controlled trials examining any age group, BD phase, treatment, control, or outcome. Primary outcomes included BD episode-specific symptoms and relapse, and acceptability. Secondary outcomes included response, remission, switch to mania, and tolerability. Certainty of evidence was assessed using the GRADE framework. Interventions effective across outcomes and phases were also identified. A Communication Hub Evidence Based Interventions-BD (EBI-BD) preference-based tool was developed to support shared decision-making using the TOPSIS multicriteria decision analysis method, incorporating user-defined outcome weights. Treatment effects were also grouped based on Neuroscience Based Nomenclature (NbN) classes.
Results: Seventy-seven studies met inclusion criteria (21 NMAs, 56 MAs), including 116 unique pharmacological (n=74), brain stimulation (n=18), nutraceutical (n=13), psychosocial (n=8), and circadian rhythm-based (n=3) treatments as monotherapy, augmentation, or combination therapy, plus five control interventions. These studies covered 133 unique outcomes (45 efficacy, 88 safety) resulting in 2,510 meta-analyses with GRADE certainty ratings of high (n=236), moderate (n=827), low (n=986), and very low (n=461). Full results are freely available in the EBI-BD platform [https://ebibd-database.org], including the preference-based tool (12 interventions, 17 safety outcomes). Interventions effective across outcomes varied by phases. For bipolar depression, they were cariprazine, divalproex/valproate, fluoxetine, ketamine (augmentation), lamotrigine, lumateperone, lurasidone, olanzapine, olanzapine+fluoxetine, quetiapine (adults), and olanzapine+fluoxetine (children/adolescents). For mania, they included aripiprazole, asenapine, carbamazepine, cariprazine, divalproex/valproate, haloperidol, lithium, olanzapine, paliperidone, quetiapine (also augmentation), risperidone (also augmentation), tamoxifen, ziprasidone (adults), and aripiprazole, asenapine, olanzapine, quetiapine, and risperidone (children/adolescents). For maintenance, interventions effective across outcomes were aripiprazole (also LAI), asenapine, divalproex/valproate, lithium, olanzapine, group psychoeducation (augmentation), quetiapine, and risperidone LAI (adults). Interventions effective across phases were aripiprazole (also LAI), asenapine, cariprazine, CBT (augmentation), divalproex/valproate, lithium, olanzapine, quetiapine (also augmentation), risperidone (also augmentation and LAI) (adults).
Treatment effects by NbN classes are also available in the manuscript.

Conclusions: the EBI-BD tool informs clinicians to make evidence-based, personalized treatment decisions for BD. This resource can inform clinical guidelines and provides a foundation for continuously improving BD care as new evidence emerges.

Trial registration: Open Science Framework: https://osf.io/pjmvn/

Text
ebibd_manuscript_bmj_R5_clean_20260611_h2pm - Accepted Manuscript
Download (633kB)

More information

Accepted/In Press date: 24 June 2026
e-pub ahead of print date: 11 August 2026

Identifiers

Local EPrints ID: 514419
URI: https://eprints.soton.ac.uk/id/eprint/514419
ISSN: 0959-8138
PURE UUID: 88c7056f-df90-4117-927a-885597a49905
ORCID for Samuele Cortese: ORCID iD orcid.org/0000-0001-5877-8075

Catalogue record

Date deposited: 17 Sep 2026 14:24
Last modified: 18 Sep 2026 01:54

Export record

Altmetrics

Contributors

Author: Michele De Prisco
Author: Vincenzo Oliva
Author: Alessandro Miola
Author: Michele Fornaro
Author: Elena Dragioti
Author: Giovanni Croatto
Author: Andre F. Carvalho
Author: Michael Berk
Author: Katerina Nikolitch
Author: Gayatri Saraf
Author: Lakshmi N. Yatham
Author: Kamyar Keramatian
Author: Risa Shorr
Author: Mark Frye
Author: Balwinder Singh
Author: Damir Krinitski
Author: Mikkel Højlund
Author: Alessandro Serretti
Author: Giuseppe Fanelli
Author: Fabiano Alves Gomes
Author: Anne Sofie Hansen
Author: René Ernst Nielsen
Author: Paolo Fusar-Poli
Author: Pasquale Paribello
Author: Mirko Manchia
Author: Anees Bahji
Author: Gustavo Vazquez
Author: Spyridon Siafis
Author: Stefan Leucht
Author: Ayşegül Yildiz
Author: Richard Delorme
Author: Ayal Schaffer
Author: Brendon Stubbs
Author: Ruby Rubaiyat
Author: Eduard Vieta
Author: Christoph U. Correll
Author: David Moher
Author: Samuele Cortese ORCID iD
Author: Jess G. Fiedorowicz
Author: Joaquim Radua
Author: Corentin J. Gosling
Author: Marco Solmi
Corporate Author: et al.

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of https://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×